Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models

Published:2014-09-17 Issue:6 Volume:32 Page:2319-2326
ISSN:1021-335X
Container-title:Oncology Reports
language:en
Short-container-title:

Author:

TANAKA NOZOMU,SAKAMOTO KAZUKI,OKABE HIROYUKI,FUJIOKA AKIO,YAMAMURA KEISUKE,NAKAGAWA FUMIO,NAGASE HIDEKI,YOKOGAWA TATSUSHI,OGUCHI KEI,ISHIDA KEIJI,OSADA AKIKO,KAZUNO HIROMI,YAMADA YUKARI,MATSUO KENICHI

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third-line treatment and beyond in metastatic colorectal cancer: What do we have and what can we expect?;Critical Reviews in Oncology/Hematology;2024-10

2. TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial;British Journal of Cancer;2024-09-07

3. Tumor-associated macrophages confer resistance to chemotherapy (Trifluridine/Tipiracil) in digestive cancers by overexpressing Thymidine Phosphorylase;2024-08-19

4. Phase I study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second-line therapy for patients with metastatic colorectal cancer;Investigational New Drugs;2024-07-11

5. Impact of renal impairment on chemotherapy-induced neutropenia in patients who are treated with trifluridine/thymidine phosphorylase inhibitor + bevacizumab for metastatic colorectal cancer: A retrospective study;2024-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP